Synonyms: CVT-303 | Ranexa® | RS-43285 | RS-43285-003
ranolazine is an approved drug (FDA (2006), EMA (2008))
Compound class:
Synthetic organic
Comment: The mechanism of action of ranolazine is largely unknown, but may have some antianginal effects by inhibition of the late sodium current in cardiac cells.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖View more information in the IUPHAR Pharmacology Education Project: ranolazine |
|
For advanced searching click here to open chemical structure editor
Similar Ligands |
No closely similar ligands found - try using advanced searching to find other ligands. |